NCT06651047View on ClinicalTrials.gov

PK/PD Analysis of Ceftazidime/Avibactam or Cefiderocol With or Without Fosfomycin for the Treatment of Difficult To-treat Gram-negative Infections

RecruitingOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

July 9, 2024

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2025

Conditions
Gram Negative InfectionAntimicrobial Resistance (AMR)
Trial Locations (11)

10126

NOT_YET_RECRUITING

Città della salute e della Scienza, Molinette, Turin

20157

NOT_YET_RECRUITING

ASST-FBF-Sacco, Milan

35128

NOT_YET_RECRUITING

Azienda Ospedale - Università Padova, Padua

40138

RECRUITING

Irccs Aoubo, Bologna

53100

NOT_YET_RECRUITING

Azienda Ospedaliero Universitaria Senese, Siena

90127

NOT_YET_RECRUITING

Istituto mediterraneo per i trapianti e terapie ad alta specializzazione (ISMETT), Palermo

95124

NOT_YET_RECRUITING

Azienda Ospedaliera di Rilievo Nazionale e di Alta Specializzazione (ARNAS) Garibaldi, Catania

00100

NOT_YET_RECRUITING

Policlinico Umberto I, Rome

00128

NOT_YET_RECRUITING

Policlinico Universitario Campus Bio-Medico, Rome

00165

NOT_YET_RECRUITING

Ospedale Pediatrico Bambin Gesù, Rome

00168

NOT_YET_RECRUITING

Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome

All Listed Sponsors
lead

University of Bologna

OTHER